NCT04909359View on ClinicalTrials.gov

Characterization of CD Responders to Vedolizumab

CompletedOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

August 25, 2015

Primary Completion Date

May 15, 2018

Study Completion Date

May 18, 2020

Conditions
Crohn DiseaseUlcerative Colitis
Trial Locations (1)

33136

University of Miami, Miami

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

University of Miami

OTHER